Correlation of thiopurine methyltransferase and inosine triphosphate pyrophosphatase polymorphisms and adverse effects induced by azathioprine treatment in Taiwanese dermatology patients

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Dermatologica Sinica

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.DSI.2013.07.001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

  2016cited by this paper
• Therapie der schweren atopischen Dermatitis bei Erwachsenen

  2012cited by this paper
• Immunosuppressive therapy for autoimmune bullous diseases.

  2012cited by this paper
• How are thiopurines used and monitored by Swedish gastroenterologists when treating patients with inflammatory bowel disease?

  2011cited by this paper
• CORRIGENDUM: Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

  2011cited by this paper
• Off-label use of azathioprine in dermatology: a systematic review.

  2011cited by this paper
• Azathioprine-related myelosuppression in a patient homozygous for TPMT*3A

  2011cited by this paper
• Assessment of Thiopurine S-Methyltransferase Activity in Patients Prescribed Thiopurines: A Systematic Review

  2011cited by this paper
• Systematic Review of Thiopurine Methyltransferase Genotype and Enzymatic Testing Strategies

  2011cited by this paper
• A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study.

  2011cited by this paper
• Influences of Thiopurine Methyltransferase Genotype and Activity on Thiopurine-induced Leukopenia in Korean Patients With Inflammatory Bowel Disease: A Retrospective Cohort Study

  2010cited by this paper
• Thiopurine Methyltransferase Gene Polymorphisms in Chinese Patients with Inflammatory Bowel Disease

  2009cited by this paper
• Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment

  2009cited by this paper
• Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine‐related adverse drug reactions in the Chinese kidney transplant recipients

  2009cited by this paper
• TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients

  2009cited by this paper
• Azathioprine-Induced Severe Bone Marrow Toxicity-A Report of 3 Cases

  2009cited by this paper
• BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.

  2008cited by this paper
• Thiopurine S-methyltransferase genotypic analysis in autoimmune bullous diseases.

  2008cited by this paper
• Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription

  2007cited by this paper
• Azathioprine: a guide for the management of dermatology patients

  2007cited by this paper
• Analysis of ITPA Phenotype-Genotype Correlation in the Bulgarian Population Revealed a Novel Gene Variant in Exon 6

  2007cited by this paper
• Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy

  2007cited by this paper
• Explaining TPMT genotype/phenotype discrepancy by haplotyping of TPMT*3A and identification of a novel sequence variant, TPMT*23

  2007cited by this paper
• Azathioprine in dermatology: the past, the present, and the future.

  2006cited by this paper
• Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.

  2006cited by this paper
• Molecular analysis of thiopurine S‐methyltransferase alleles in Taiwan aborigines and Taiwanese

  2006cited by this paper
• Pharmacogenomics in inflammatory bowel disease.

  2006cited by this paper
• The clinical pharmacology of 6-mercaptopurine

  2005cited by this paper
• ITPA genotyping test does not improve detection of Crohn’s disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression

  2005cited by this paper
• Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency in the Japanese population.

  2005cited by this paper
• Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease

  2004cited by this paper
• Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).

  2004cited by this paper
• Frequency Distribution of Thiopurine S-Methyltransferase Activity in Red Blood Cells of a Healthy Japanese Population

  2004cited by this paper
• Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine.

  2004cited by this paper
• Pharmacogenetics of Thiopurine S-Methyltransferase and Thiopurine Therapy

  2004cited by this paper
• Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants.

  2004cited by this paper
• Guidelines for prescribing azathioprine in dermatology

  2004cited by this paper
• Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency

  2002cited by this paper
• Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease

  2002cited by this paper
• TPMT in the treatment of Crohn's disease with azathioprine

  2002cited by this paper
• Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.

  2002cited by this paper
• Childhood hyperuricemia and acute renal failure resulting from a missense mutation in the HPRT gene.

  2002cited by this paper
• Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.

  2001cited by this paper
• Adverse effects of azathioprine in the treatment of inflammatory bowel disease.

  2001cited by this paper
• Thiopurine methyltransferase activity in the Jewish population of Israel

  2001cited by this paper
• Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia

  2000cited by this paper
• Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

  2000cited by this paper
• The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.

  1999cited by this paper
• A pharmacogenetic basis for the safe and effective use of azathioprine and other thiopurine drugs in dermatologic patients.

  1995cited by this paper
• Thiopurine methyltransferase activity in American white subjects and black subjects

  1994cited by this paper
• Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.

  1993cited by this paper
• Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism

  1989cited by this paper
• Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

  1980cited by this paper

• Taiwanese dermatological association (TDA) consensus for the management of pemphigus.

  2022cites this paper
• Individualized medication based on pharmacogenomics and treatment progress in children with IgAV nephritis

  2022cites this paper
• An electrochemical platform for the selective detection of azathioprine utilizing a screen-printed carbon electrode modified with manganese oxide/reduced graphene oxide

  2021cites this paper
• Predictive Value of NUDT15 Variants on Neutropenia Among Han Chinese Patients with Dermatologic Diseases: A Single-Center Observational Study

  2020cites this paper
• Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review

  2020cites this paper
• Maintenance therapy with azathioprine prolonged duration of remission for pemphigus patients who received rituximab as first-line or add-on therapy.

  2019cites this paper
• ITPA Activity in Children Treated by Azathioprine: Relationship to the Occurrence of Adverse Drug Reactions and Inflammatory Response

  2018cites this paper
• ITPA Activity in Adults and Children Treated With or Without Azathioprine: Relationship Between TPMT Activity, Thiopurine Metabolites, and Co-medications

  2017cites this paper
• Étude phénotypique des enzymes du métabolisme des thiopurines (ITPA, IMPDH), lien avec les métabolites thiopuriques et optimisation thérapeutique en gastro-entérologie

  2016influential citation